MorphoSys Announces Extension of Antibody Collaboration with Bayer
December 08, 2005 01:48 ET
|
MorphoSys AG
MARTINSRIED, Germany, Dec. 8, 2005 (PRIMEZONE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment, TecDAX) announced today the extension of its collaboration with Bayer Pharmaceuticals...
MorphoSys Raises Revenue and Earnings Estimates for 2005
December 08, 2005 01:41 ET
|
MorphoSys AG
MARTINSRIED, Germany, Dec. 8, 2005 (PRIMEZONE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment, TecDAX) today announced an updated guidance for the financial year 2005. Revenue guidance for...
MorphoSys and Wacker Demonstrate High Yield Expression of Antibody Fragments
November 07, 2005 02:13 ET
|
MorphoSys AG
MARTINSRIED, Germany, Nov. 7, 2005 (PRIMEZONE) -- A feasibility study conducted by Wacker Biotech GmbH on behalf of MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment, TecDAX) using Fab fragments,...
MorphoSys Reports Nine Months 2005 Results
October 27, 2005 01:42 ET
|
MorphoSys AG
MARTINSRIED, Germany, Oct. 27, 2005 (PRIMEZONE) -- MorphoSys AG (Frankfurt: MOR; Prime Standard Segment, TecDAX) today reported financial results according to IFRS for the first nine months ended...
MorphoSys Appoints Dr. Marlies Sproll as Chief Scientific Officer and Member of the Management Board
October 27, 2005 01:37 ET
|
MorphoSys AG
MARTINSRIED, Germany, Oct. 27, 2005 (PRIMEZONE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment, TecDAX) today announced the appointment of Dr. Marlies Sproll (47) as Chief Scientific Officer...
MorphoSys Raises Earning Estimates for 2005
October 26, 2005 16:25 ET
|
MorphoSys AG
MARTINSRIED, Germany, Oct. 26, 2005 (PRIMEZONE) -- MorphoSys AG (Frankfurt:MOR)(Prime Standard Segment,TecDAX) today announced an updated guidance for the financial year 2005. MorphoSys increased its...
MorphoSys Starts Multiple Antibody Programs with Schering AG
October 10, 2005 01:38 ET
|
MorphoSys AG
MARTINSRIED, Germany, Oct. 10, 2005 (PRIMEZONE) -- MorphoSys AG (Frankfurt Stock Exchange:MOR) (Prime Standard Segment:TecDAX) announced today the start of a further three therapeutic antibody...
MorphoSys Announces Cross Licensing of Technologies with Lilly: AME Patent Dispute Settled
September 23, 2005 02:35 ET
|
MorphoSys AG
MARTINSRIED, Germany, Sept. 23, 2005 (PRIMEZONE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment:TecDAX) today announced a cross license agreement with Eli Lilly and Company on the use of...
MorphoSys Announces Agreement with Japanese Pharmaceutical Company Shionogi
September 07, 2005 19:49 ET
|
MorphoSys AG
MARTINSRIED, Germany, Sept. 7, 2005 (PRIMEZONE) -- MorphoSys AG (Frankfurt:MOR) and Shionogi & Co., Ltd. announced today that they have signed a three-year license agreement on the use of...
MorphoSys Starts New Antibody Program With Centocor
September 06, 2005 02:00 ET
|
MorphoSys AG
MARTINSRIED, Germany, Sept. 6, 2005 (PRIMEZONE) -- MorphoSys AG (Frankfurt: MOR; Prime Standard Segment, TecDAX), today announced that within the scope of its collaboration with Centocor Inc., a...